Takashi M, Haimoto H, Koshikawa T, Kato K
Department of Urology, Nagoya University School of Medicine, Japan.
Am J Clin Pathol. 1990 May;93(5):631-6. doi: 10.1093/ajcp/93.5.631.
The authors localized aldolase C in renal tubules and renal cell carcinoma by immunohistochemical study and quantitative analysis by an enzyme immunoassay. Aldolase C was localized in epithelial cells of loops of Henle and collecting ducts and in those of Bowman's capsules. In renal cell carcinoma, aldolase C was immunohistochemically demonstrated in 95% (41 of 43) of cases, including one sarcomatoid variant. The tissue concentrations of aldolase C in the renal cortex (n = 8) were 12.7 +/- 6.2 micrograms/g protein (mean +/- standard deviation), and those of the medulla (n = 8) were 20.3 +/- 6.9 micrograms/g protein. On the other hand, the concentrations in renal cell carcinoma (n = 26) were 93.5 +/- 95.9 micrograms/g protein: about seven times higher than that in renal cortex (P less than 0.001). These findings indicate that aldolase C was first expressed in renal cell carcinoma, which is derived from proximal renal tubules, because proximal renal tubules had aldolase B but not aldolase C.
作者通过免疫组织化学研究和酶免疫测定的定量分析,将醛缩酶C定位在肾小管和肾细胞癌中。醛缩酶C定位于髓袢和集合管的上皮细胞以及鲍曼囊的上皮细胞中。在肾细胞癌中,95%(43例中的41例)的病例通过免疫组织化学检测显示有醛缩酶C,包括1例肉瘤样变体。肾皮质(n = 8)中醛缩酶C的组织浓度为12.7±6.2微克/克蛋白质(平均值±标准差),髓质(n = 8)中的浓度为20.3±6.9微克/克蛋白质。另一方面,肾细胞癌(n = 26)中的浓度为93.5±95.9微克/克蛋白质:约为肾皮质中浓度的7倍(P < 0.001)。这些发现表明,醛缩酶C首先在源自近端肾小管的肾细胞癌中表达,因为近端肾小管中有醛缩酶B但没有醛缩酶C。